AMIGOs is a research group focused on improving treatment and care of patients with Merkel Cell Carcinoma. Coordinated by @MASC_Trials
Joined March 2019
- Tweets 215
- Following 36
- Followers 159
- Likes 364
69 Photos and videos
☀️ News: PBAC recommends broad listing for nivolumab & ipilimumab for treatment of advanced/metastatic cancer. Next step: Minister Butler’s approval to list the medicines on the PBS—unlocking wider access to life-saving treatment especially for those with rare cancers!
25
The I-MAT trial has enrolled 122 participants across Australia and New Zealand, surpassing its target of 120! 🎉Thanks to Prof Victoria Atkinson's team at Princess Alexandra Hospital and Dr Gareth Rivalland's team at Auckland City Hospital for enrolling the final participants 👏
77
Congrats to the GoTHAM Trial team at Sir Charles Gairdner Hospital, led by A/Prof Tarek Meniawy, for enrolling WA's first participant! The GoTHAM trial has 18 participants across 10 sites in Australia. #Merkelcellcarcinoma #SkinCancer #ClinicalTrials #ClinicalResearch #MCC
70
Merkel cell carcinoma clinical trials session, MASC Trials ASM (24 October 24) with A/Prof Alex Guminski and Dr Wen Xu presenting updates on the GoTHAM and I-MAT trials with Trevor Day, consumer sharing his story - My journey so far!
1
2
212
Angela Cairns, Manager at #TransplantAustralia, and mum, wife, and daughter-in-law of heart recipients is presenting ‘Transplant recipients and skin cancer: The lived experience’ at the 2024 MASC Trials ASM, 24 Oct in Sydney. Seats are limited! Register: masc.org.au/asm-2024/
75
Ana Ratapu, stage IV melanoma survivor with a clinical nursing background caring for melanoma and breast cancer patients, is presenting ‘An international journey to access a clinical trial’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
64
Dr Wen Xu, senior lecturer at University of Queensland is presenting ‘Immunotherapy Merkel Adjuvant Trial (I-MAT) and Australasian Merkel Cell Carcinoma Interest Group (AMIGOs)’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
71
Australasian Merkel Cell Carcinoma Interest Group retweeted
BETTER trial is investigating new treatment combo using immunotherapy drugs & targeted radiotherapy for patients with melanoma brain metastases. Thanks to a generous donation from @AusSkinCancer Foundation, this trial is in start-up phase. masc.org.au/better/
@Mal_Ameratunga
6
14
825
The @MASC_Trials 2024 Annual Scientific Meeting has a session dedicated to Merkel cell carcinoma clinical trials, research advances, and consumer perspectives. Register today👇
📢 ASM Program available!
✅2 keynote speakers
✅17 melanoma and skin cancer clinical trial experts
✅6 consumers with unique perspectives on clinical trials.
Visit the MASC Trials ASM website for program & speaker info. Register ASAP - seats are limited!
masc.org.au/asm-2024/
2
81
Australasian Merkel Cell Carcinoma Interest Group retweeted
Anne Gately is a stage IV melanoma survivor, author of Sunburnt & wants to change the ‘bronzed Aussie’ culture. Hear her talk on ‘How Australia’s culture primed us for skin cancer’ at the 2024 MASC Trials ASM, 24 Oct 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
4
8
309
Our Consumer Advisory Panel has welcomed a new member to represent Merkel cell carcinoma (MCC) patients. Trevor Day was diagnosed with MCC – a rare form of skin cancer – in 2020. Trevor hopes to help people understand the physical and mental aspects of dealing with MCC.
2
100
🚨 EOFY is tomorrow! Don’t miss your opportunity to contribute to cutting-edge melanoma and skin cancer clinical trials. By donating, you're supporting innovative research that can help melanoma patients like Ana Ratapu. Please donate: masc.org.au/donate/
61
High-quality clinical trials require continuous funding to deliver real-world results. Help us to conquer melanoma and skin cancer, including Merkel cell carcinoma, with clinical trials. Make a tax-deductible donation before 30 June 2024. Donate: masc.org.au/donate/
63
Australasian Merkel Cell Carcinoma Interest Group retweeted
After Paul Beard's lung transplant, the immunosuppressant drugs he needed led to skin cancers. Paul enrolled in the SiroSkin trial, which is testing whether a topical cream can reduce the burden of facial skin cancers in organ transplant recipients.
masc.org.au/paul/
2
5
783
Australasian Merkel Cell Carcinoma Interest Group retweeted
By the time Peter Wilson was diagnosed with stage IV melanoma, the cancer had spread to his brain & lungs. Thankfully, Peter responded well to the treatment he received as part of a clinical trial. Please donate to help more melanoma patients like Peter:
masc.org.au/donate/
2
5
220
The I-MAT trial, investigating #immunotherapy in #MerkelCellCarcinoma patients after initial surgery and/or radiotherapy, has enrolled 100 participants. We thank Dr Daniel Xing, Rachel Doyle & the team at @TownsvilleHHS for enrolling their first & the trial’s 100th participant.
1
90
Join us in celebrating International Clinical Trials Day on 20 May! At Melanoma & Skin Cancer Trials, we're proud to work with a dedicated multi-disciplinary global network to deliver clinical trials that are improving outcomes for melanoma & skin cancer patients around the world
3
84
Australasian Merkel Cell Carcinoma Interest Group retweeted
💪 Join us in the fight against melanoma & skin cancer! Donate to help melanoma patients like John access clinical trials. 3 years ago, John was told he had only months to live. Thanks to our CHARLI trial, John’s scans are all clear! Donate: masc.org.au/donate/
@AuNutrien
1
1
156
Australasian Merkel Cell Carcinoma Interest Group retweeted
👁️ Want to hear the latest in ocular melanoma but have plans for Sat 15 June? Or do you live outside of Australia and the time zone doesn’t match your schedule? You can access the AOMA Summit session videos AFTER the event, but you still need to register: masc.org.au/aoma-summit/
2
3
220
There will be a #MerkelCellCarcinoma #CliniclTrials session with talks from Wen Xu & Alex Guminski.
Register details 👇
@SandhuShahneen @RareCancers
@MerkelCellCA @rare_arc
Clinical trial discoveries to be the focus of Melanoma & Skin Cancer Trials 2024 Annual Scientific Meeting, 24 Oct, Hyatt Regency Sydney. Register: masc.org.au/asm-2024/
@UTS_CQUEST @MelanomaAus @MelanomaACEMID @DrVictoriaMar @kiakho @HaassLab @ProfSNicholls @DWhitemanQIMRB
4
157